Parabilis Medicines Inc.
PBLS | NASDAQ
$27.34
-$0.98 (-3.46%)
Nov 2, 2026, 12:04 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 |
|---|---|---|---|---|
PE Ratio | -0.74 | -0.57 | -0.83 | -0.84 |
PEG Ratio | 0.01 | n/a | 0.01 | n/a |
PS Ratio | 5.35K | n/a | n/a | n/a |
PB Ratio | 0.76 | 0.17 | n/a | n/a |
P/FCF Ratio | -14.70 | -0.51 | -0.62 | -1.18 |
P/OCF Ratio | -14.98 | -0.51 | -0.62 | -1.18 |
OCF/S Ratio | -2.45K | n/a | n/a | n/a |
Debt / Equity Ratio | 0.05 | 0.22 | n/a | n/a |
Quick Ratio | 17.91 | 6.12 | n/a | n/a |
Current Ratio | 17.91 | 6.12 | n/a | n/a |
Asset Turnover | 0 | n/a | n/a | n/a |
Interest Coverage | -242.31 | -162.51 | -92.22 | -100.85 |
Return on Equity | -5.01% | -18.56% | n/a | n/a |
Return on Assets | -4.46% | -11.80% | n/a | n/a |
Return on Invested Capital | -4.52% | -13.66% | n/a | n/a |
Dividend Yield | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a |
Gross Profit Margin | 100% | n/a | n/a | n/a |
Net Profit Margin | -35.45K% | n/a | n/a | n/a |
Pretax Profit Margin | -35.45K% | n/a | n/a | n/a |
Operating Profit Margin | -34.38K% | n/a | n/a | n/a |
FCF Margin | -2.86K% | n/a | n/a | n/a |
EBITDA Margin | -34.91K% | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove PBLS